Nanoviricides (NNVC) Accumulated Expenses (2011 - 2026)
Nanoviricides' Accumulated Expenses came in at $38,331 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 47.6% from $25,969 a year earlier and up 47.4% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Accumulated Expenses (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, Nanoviricides' Accumulated Expenses data covers 61 quarters.
- Accumulated Expenses carries a five-year compound annual growth rate of 9.6% (FY2021 to FY2026).
- Going back by fiscal year, Accumulated Expenses was $25,969 in FY2025 (-90.1%), $262,467 in FY2024 (+82.6%), $143,760 in FY2023 (+214.6%) and $45,692 in FY2022 (+88.1%).
- The five-year range for quarterly Accumulated Expenses is $23,712 (fiscal Q1 2023) to $339,623 (fiscal Q1 2024).
- Year-over-year, Accumulated Expenses increased in 1 of the last eight quarters, with an average decline of 43.4%.
- The fastest year-over-year change in Accumulated Expenses over five years came in fiscal Q3 2024 (growth of 513.7%), and the weakest in fiscal Q1 2026 (a decline of 90.7%).
- Business Quant data shows NNVC's Accumulated Expenses at $26,000 (Q3 2026), $48,380 (Q2 2026) and $26,300 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.64 Bn | 1,139.22 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 640.54 Bn | 559.06 Bn | 17.26 Bn |
| 3 | AbbVie | 501.78 Bn | 474.89 Bn | 12.70 Bn |
| 4 | Merck | 374.95 Bn | 329.32 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.43 Bn | 266.42 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.31 Bn | 241.99 Bn | 12.86 Bn |
| 7 | Amgen | 242.70 Bn | 198.10 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.64 Bn | 167.84 Bn | 6.22 Bn |
| 9 | Pfizer | 172.34 Bn | 118.98 Bn | 10.94 Bn |
| 10 | Nanoviricides | 29.88 Mn | 17.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,331.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 48,380.00 |
| Sep 30, 2025 | 26,300.00 |
| Jun 30, 2025 | 25,969.00 |
| Mar 31, 2025 | 32,616.00 |
| Dec 31, 2024 | 65,424.00 |
| Sep 30, 2024 | 283,292.00 |
| Jun 30, 2024 | 262,467.00 |
| Mar 31, 2024 | 258,795.00 |
| Dec 31, 2023 | 180,372.00 |
| Sep 30, 2023 | 339,623.00 |
| Jun 30, 2023 | 143,760.00 |
| Mar 31, 2023 | 42,168.00 |
| Dec 31, 2022 | 51,877.00 |
| Sep 30, 2022 | 23,712.00 |
| Jun 30, 2022 | 45,692.00 |
| Mar 31, 2022 | 25,252.00 |
| Dec 31, 2021 | 24,157.00 |
| Sep 30, 2021 | 24,075.00 |
API Access
Nanoviricides Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();